Enhanced chemotherapy response in hepatocellular carcinoma: synergistic effects of miR-122 and doxorubicin co-delivery system inducing apoptosis and DNA damage-Reference-Cited by-同舟云学术

Enhanced chemotherapy response in hepatocellular carcinoma: synergistic effects of miR-122 and doxorubicin co-delivery system inducing apoptosis and DNA damage

Published:2024-08-28 Issue:1 Volume:15 Page:
ISSN:1868-6958
Container-title:Cancer Nanotechnology
language:en
Short-container-title:Cancer Nano

Author:

Lin Xiuyun,Liu Jie,Wu Guangfeng,Yang Xiu,Yan Wenqiang,Fan Nanfeng,Li Hui

Funder

the Startup Fund for scientific research, Fujian Medical University

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12645-024-00287-x.pdf

Reference26 articles.

1. Agirre M, Zarate J, Ojeda E, Puras G, Desbrieres J, Pedraz J (2014) Low molecular weight chitosan (LMWC)-based polyplexes for pDNA delivery: from bench to bedside. Polymers 6(6):1727–1755. https://doi.org/10.3390/polym6061727

2. Bracken CP, Scott HS, Goodall GJ (2016) A network-biology perspective of microRNA function and dysfunction in cancer. Nat Rev Genet 17(12):719–732. https://doi.org/10.1038/nrg.2016.134

3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492

4. Cao F, Yin L-X (2019) miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway. Exp Mole Pathol 106:34–43. https://doi.org/10.1016/j.yexmp.2018.10.009

5. Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S et al (2009) MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 69(14):5761–5767. https://doi.org/10.1158/0008-5472.can-08-4797